Category: Doctors

Dr. Rod Rohrich Headlining Surgical Seminars

One of the world’s most influential plastic surgeons, Dr. Rod J. Rohrich will disseminate his insight and expertise that extends from taking part in panel discussions to performing live surgery.

Dr. Rohrich, who is Board Certified by the American Board of Plastic Surgery, runs his clinical practice at University Hospitals/UT Southwestern Medical Center and the Dallas Plastic Surgery Institute.

Starting on February 8-10 of next year, Dr. Rohrich will moderate two panels at the 52nd Annual Baker Gordon Educational Symposium in Miami. He is one of the faculty members of the symposium which is the largest live surgery symposium in the country.

The first panel he will mediate deals with blepharoplasty or the cosmetic surgical procedure that improves the appearance of the eyelids while the second panel will discuss results of body contour surgeries, (http://medicaldailytimes.com/medicine/dr-rod-j-rohrich-attend-several-symposia-2018/3004/).

In addition, he will take part in lectures at the symposium as well as perform primary open rhinoplasty.

Shortly after the symposium, Dr. Rohrich will be chairing two meetings in Dallas, both of which he organized. The 21st Annual Global Dallas Cosmetic Surgery and Medicine Meeting which will be held on February 28 through March 2 and the 35th annual Dallas Rhinoplasty Meeting which will run March 2 – 3.

Dr. Rohrich will also be actively participating in both meetings taking part in panel sessions and moderating sessions.

The first meeting will call attention to the latest advances in lasers, noninvasive fat removal, skin care enhancements along with cosmetic surgery techniques and more.

At the Rhinoplasty Meeting common rhinoplasty problems as well as the newest developments will be discussed and lectures will tackle issues such as diagnosing familiar and unfamiliar difficulties and evaluating the nose.

Active for more than two decades, Dr. Rohrich, who has functioned as the president of the American Society of Plastic Surgeons (ASPS), is a member of the American Association of Plastic Surgeons, the Plastic Surgery Council and more.

He is also an active civic leader and philanthropist having worked on the Board of Directors of the March of Dimes, Save the Children and the Dallas Chapter of the American Cancer Society. He is a founding member of the Dallas for Children Foundation which helps underprivileged children.

Dr. Rohrich graduated with degrees from North Dakota State University and the University of North Dakota and received his medical degree from Baylor University College of Medicine. He also studied pediatric plastic surgery at Oxford University.

Dr. Mark McKenna and OVME are Improving the Field of Elective Healthcare

A recent interview on the Idea Mensch website spotlights Dr. Mark McKenna, a very accomplished Medical Doctor from the Atlanta, Georgia area.

A native of the New Orleans, Louisiana region, Doctor McKenna graduated from Tulane University Medical School, and is licensed in medicine and surgery in both Florida and Georgia. In addition to his formal medical training, Mark McKenna has founded a real estate development company, and has acquired and/or started two other real estate-related companies.

As the owner of the Shape Medical Wellness Center, Dr. McKenna oversaw the leading non-surgical aesthetic and medical weight loss clinic in Atlanta, Georgia for many years. After the Shape Medical practice was sold to Life Time Fitness Inc. in 2014, McKenna stayed on with Life Time Fitness, as the company’s national medical director. In July of 2017, Dr. McKenna founded a new, high-tech medical aesthetic company that is named OVME, and he serves as the company’s CEO.

In the Idea Mensch interview, Doctor McKenna states that after working in the medical aesthetics field for more than a decade, he learned of many ways to change and improve the industry. OVME is a consumer-facing company that is actively changing the scope of modern elective healthcare.

When asked how he turns ideas into reality, Dr. McKenna says that he consistently sets goals, meditates and practices visualization techniques. This married father of a young daughter says that this combination of practices generally leads to good decisions.

An important development in Dr. McKenna’s life came about when Hurricane Katrina hit New Orleans in 2005. Although he suffered major personal business losses, Mark McKenna was able to give back by taking part in the redevelopment of much-needed housing in the city.

If he were given the chance to do things over again, Dr. Mark McKenna says he might take more time to truly find his passion. The doctor also says that being a big reader and working with people that are smarter than himself, are other traits that can help to make a person a more productive entrepreneur.

Learn more about him: https://doctor.webmd.com/doctor/6271508/mark-mckenna-md-ratings

Mikhail Blagosklonny, the Scientist behind Rapamycin

Mikhail Blagosklonny is a research scientist focusing on the study cancer and aging. He is also an instructor teaching oncology at the Roswell Park Cancer Institute. He is also a philanthropist. In the scientific community, he works as editor-in-chief for several publications such as Oncotarget, Aging, and Cell Cycle. Mikhail Blagosklonny studied at the First Pavlov State Medical University of St. Peterburg, where he earned a Master’s degree in internal medicine as well as a Ph.D. in experimental medicine. In 2002, he was employed as an assistant professor of medicine at New York Medical College in Valhalla. He later served as a senior scientist at Ordway Research Institute in Albany, New York.

Mikhail Blagosklonny is interested in cancer and cancer therapies that protect normal cells from damage research. He also specializes in the mechanism of aging and anti-aging drugs. He is one of the dedicated doctors who are very skilled in areas of oncology and hematology. He is well-known in carrying various clinical experiments in order to come up with a better treatment of cancer to patients. Mikhail and his devoted team of oncologists and hematologists offer specialized care to their patients. They are at all-time ready to offer treatment at The Roswell Park Cancer Institute. They give personalized treatments owing that patients have different genetic makeups and patients are affected differently by cancer.

Mikhail Blagosklonny is well recognized through one of his discoveries of Rapamycin. Rapamycin is a drug with implausible healing properties. The drug is used to prevent tissue rejection after transplanting an organ successfully. According to Mikhail, the drug is also convenient in hemolytic-uremic syndrome treatment. This is because the drug not only reduces the level of toxicity after a kidney transplant but also prevents rejection of the new organ. Mikhail also claims that the drug has other benefits in the general human body apart from fighting cancer. The drug can effectively treat Lymphangioleiomyomatosis as well as tuberous sclerosis complex which affects several acute organs like the brain, kidney, and the heart.

Mikhail Blagosklonny also believes that Rapamycin contains a property that can prolong a person’s life. He has done experiments on mice that show promising results even though tests on humans are yet to be done. He also says that the drug can be used to treat muscular dystrophy, which is weakening of muscles. He has shown this through mice tests that showed a development of strength by over 30%. Although research is going on, he has self-confidence that the drug can be used to correct mental effects and be used to prevent and treat Alzheimer disease.

Mikhail Blagosklonny continues to undertake research that will continue being of importance within the oncology field. He has been a role model to his peers and students who want to be part of the team that will advance his research in future. He has made a big progress in the field and his hope is that this has inspired many individuals who will pick up and continue with the research after him. He is focused on making sure that the treatment of cancer will be easy and a cost affordable treatment in future.